Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $0.86

Biomerica, Inc. (NASDAQ:BMRAGet Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.86 and traded as low as $0.43. Biomerica shares last traded at $0.44, with a volume of 49,424 shares traded.

Biomerica Stock Performance

The stock has a market capitalization of $7.40 million, a price-to-earnings ratio of -1.19 and a beta of -0.97. The company has a fifty day simple moving average of $0.58 and a 200 day simple moving average of $0.86.

Biomerica (NASDAQ:BMRAGet Free Report) last announced its earnings results on Friday, April 12th. The company reported ($0.11) EPS for the quarter. The company had revenue of $1.02 million for the quarter. Biomerica had a negative return on equity of 64.00% and a negative net margin of 117.46%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Biomerica stock. Fore Capital LLC grew its holdings in Biomerica, Inc. (NASDAQ:BMRAFree Report) by 72.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,680 shares of the company’s stock after purchasing an additional 25,000 shares during the quarter. Fore Capital LLC owned about 0.35% of Biomerica worth $50,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 22.28% of the stock is currently owned by institutional investors.

About Biomerica

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Recommended Stories

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.